focus -WSS

focus

author：Wikipedia 2025-10-01 04:32:52 - browse：27

Brain cancer — Michelle Monje/Stanford University/NIH

Tocagen (TOCA) said Tuesday that a Phase 3 clinical trial involving a novel gene therapy for aggressive brain tumors will continue to a final analysis later this year, following an interim look at patient survival data conducted by independent monitors. Tocagen’s stock price dropped sharply.

The San Diego-based biotech pitched the study’s continuation as an encouraging sign for its gene therapy called Toca 511/Toca FC, which is designed to deliver a localized chemotherapy directly to the site of brain tumors.

“We believe the longer-term follow-up of patients in the final analysis, particularly for those randomized in the second enrollment period, will be important in assessing both primary and secondary endpoints,” said Tocagen CEO Marty Duvall, in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Novo: Oral version of Ozempic leads to 15% weight loss

WSS

Eli Lilly’s Mounjaro succeeds in second weight

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Senate panel passes drug pricing bills, but drops one PBM reform

The thinking behind the controversial eating disorder chatbot Tessa

Bispecific antibodies are next new thing in cancer immunotherapy

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

focus

focus

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

The thinking behind the controversial eating disorder chatbot Tessa

Bright Health sells Medicare Advantage business to Molina

Biogen nominates mother of director’s child to replace him on board

Drug repurposing or repositioning? The language matters

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Timeline: Key moments in fight for gay rights

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

hotspot

Xenotransplantation trials will require adjusting expectations, experts say

The thinking behind the controversial eating disorder chatbot Tessa

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Reanimated hearts work just as well for transplants, study finds

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

Eli Lilly’s Mounjaro succeeds in second weight

entertainment

entertainment

entertainment

focus